These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Phosphoprotein Enrichment for Protein Analysis in Motile T-Lymphocytes. Prasannan P; Saravanan R; Verma NK Methods Mol Biol; 2019; 1930():83-90. PubMed ID: 30610602 [TBL] [Abstract][Full Text] [Related]
46. Exploring the phosphoproteome with mass spectrometry. Peters EC; Brock A; Ficarro SB Mini Rev Med Chem; 2004 Mar; 4(3):313-24. PubMed ID: 15032677 [TBL] [Abstract][Full Text] [Related]
47. New tools for quantitative phosphoproteome analysis. Conrads TP; Issaq HJ; Veenstra TD Biochem Biophys Res Commun; 2002 Jan; 290(3):885-90. PubMed ID: 11798155 [TBL] [Abstract][Full Text] [Related]
48. Temporal characterization of the non-structural Adenovirus type 2 proteome and phosphoproteome using high-resolving mass spectrometry. Källsten M; Gromova A; Zhao H; Valdés A; Konzer A; Pettersson U; Lind SB Virology; 2017 Nov; 511():240-248. PubMed ID: 28915437 [TBL] [Abstract][Full Text] [Related]
49. Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. Zanivan S; Gnad F; Wickström SA; Geiger T; Macek B; Cox J; Fässler R; Mann M J Proteome Res; 2008 Dec; 7(12):5314-26. PubMed ID: 19367708 [TBL] [Abstract][Full Text] [Related]
50. Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. Peng X; Xu F; Liu S; Li S; Huang Q; Chang L; Wang L; Ma X; He F; Xu P J Proteome Res; 2017 Dec; 16(12):4364-4373. PubMed ID: 28857561 [TBL] [Abstract][Full Text] [Related]
51. Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome. Guo T; Lee SS; Ng WH; Zhu Y; Gan CS; Zhu J; Wang H; Huang S; Sze SK; Kon OL Cell Mol Life Sci; 2011 Jun; 68(11):1983-2002. PubMed ID: 20953656 [TBL] [Abstract][Full Text] [Related]
52. Deciphering signaling control by phosphoproteome using mass spectrometry. Leung YK; Ho JW Protein Pept Lett; 2006; 13(5):467-9. PubMed ID: 16800799 [TBL] [Abstract][Full Text] [Related]
53. Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus. Schultze FC; Petrova DT; Oellerich M; Armstrong VW; Asif AR Cell Prolif; 2010 Aug; 43(4):396-404. PubMed ID: 20590665 [TBL] [Abstract][Full Text] [Related]
54. Quantitative Phosphoproteomic Analysis Reveals Key Mechanisms of Cellular Proliferation in Liver Cancer Cells. Zhu B; He Q; Xiang J; Qi F; Cai H; Mao J; Zhang C; Zhang Q; Li H; Lu L; Wang T; Yu W Sci Rep; 2017 Sep; 7(1):10908. PubMed ID: 28883432 [TBL] [Abstract][Full Text] [Related]
55. Functional analysis of the stable phosphoproteome reveals cancer vulnerabilities. Xiao D; Kim HJ; Pang I; Yang P Bioinformatics; 2022 Mar; 38(7):1956-1963. PubMed ID: 35015814 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive proteome and phosphoproteome profiling shows negligible influence of RNAlater on protein abundance and phosphorylation. Bae J; Kim SJ; Lee SE; Kwon W; Kim H; Han Y; Jang JY; Kim MS; Lee SW Clin Proteomics; 2019; 16():18. PubMed ID: 31049047 [TBL] [Abstract][Full Text] [Related]
57. Visualization and biochemical analyses of the emerging mammalian 14-3-3-phosphoproteome. Johnson C; Tinti M; Wood NT; Campbell DG; Toth R; Dubois F; Geraghty KM; Wong BH; Brown LJ; Tyler J; Gernez A; Chen S; Synowsky S; MacKintosh C Mol Cell Proteomics; 2011 Oct; 10(10):M110.005751. PubMed ID: 21725060 [TBL] [Abstract][Full Text] [Related]
59. Correction to: Comprehensive proteome and phosphoproteome profiling shows negligible influence of RNAlater on protein abundance and phosphorylation. Bae J; Kim SJ; Lee SE; Kwon W; Kim H; Han Y; Jang JY; Kim MS; Lee SW Clin Proteomics; 2019; 16():27. PubMed ID: 31333336 [TBL] [Abstract][Full Text] [Related]